Evidence map›Paper›PMID 41282774›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Deep-learning-derived glaucoma-related endophenotypes enable novel genome-wide genetic and functional discovery.

Liyin Chen, Yan Zhao, Saber Kazeminasab Hashemabad, Tobias Elze, Mohammad Eslami, Mengyu Wang, Janey L Wiggs, Ayellet V Segre, Nazlee Zebardast

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liyin ChenDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Yan ZhaoDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Saber Kazeminasab HashemabadDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Tobias ElzeDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Mohammad EslamiDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Mengyu WangDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Janey L WiggsDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Ayellet V SegreDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.
Nazlee ZebardastDepartment of Ophthalmology, Mass Eye and Ear, Harvard Medical School; Boston, Massachusetts, MA, USA.

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
Uncovering novel biological processes and pathogenic mechanisms for glaucomaR01EY031424 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Ayellet Vered Segre · 2020 to 2026
$4.5M
Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye AnatomyR01EY030575 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ELZE, TOBIAS · 2019 to 2023
$2.4M
Developing Population-Generalizable Deep Learning Models for Automated Glaucoma ScreeningR01EY036222 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Mengyu Wang · 2024 to 2026
$2.0M
Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine LearningR01EY036518 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Nazlee Zebardast · 2024 to 2026
$2.0M
Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for GlaucomaR21EY035298 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI WANG, MENGYU · 2023 to 2023
$557k
NEI NIH HHS P30 EY003790NEI NIH HHS P30 EY014104NEI NIH HHS R01 EY030575NEI NIH HHS R01 EY031424NEI NIH HHS R01 EY036222NEI NIH HHS R01 EY036518NEI NIH HHS R21 EY035298
6 · The paper itself

Abstract

The genetic architecture of primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, remains largely unexplained due to the reliance of previous genome-wide association studies (GWAS) on imprecise phenotypes from electronic health records. Here, we overcome this with a disease-trained, task-transfer machine learning (ML) framework that learns glaucoma-related damage patterns from a large clinical repository of 8,323 glaucoma patients. We showed that ML optical coherence tomography (OCT)-derived endophenotypes trained on 18,985 OCT scans from these patients identified novel loci associated with POAG. By applying the derived endophenotypes to 47,908 UK Biobank participants, we performed GWAS in European, African, and Asian ancestral groups followed by cross-ancestry meta-analyses. In total, we identified 36 and 43 LD-independent GWAS loci that passed genome-wide significance in the EUR and cross-ancestry meta-analysis, respectively. About two thirds of the identified loci overlapped with previously reported POAG related associations, demonstrating the validity of our approach. Importantly, more than a third (21) of the loci were novel to glaucoma. Extensive functional analyses, including Bayesian colocalization analysis, gene-based association tests, Mendelian randomization, and single-cell enrichment analysis, converged on 11 high-confidence gene effectors, five of which are novel to glaucoma. These genes support Wnt-mediated outflow dysfunction and retinal ganglion cell vulnerability in POAG pathogenesis and are potential actionable drug targets. Our findings expanded POAG genetic associations, provided mechanistic insights at cell-type resolution, and proposed plausible putative causal genes. This study provides a powerful, generalizable ML-driven strategy for accelerating the discovery of disease mechanisms and therapeutic targets for complex diseases.

Identifiers

PMID41282774
PMCPMC12637757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.